Logo image of MANH

MANHATTAN ASSOCIATES INC (MANH) Stock Fundamental Analysis

USA - NASDAQ:MANH - US5627501092 - Common Stock

208.05 USD
+9.1 (+4.57%)
Last: 10/8/2025, 3:14:55 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to MANH. MANH was compared to 281 industry peers in the Software industry. MANH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MANH is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, MANH could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MANH was profitable.
MANH had a positive operating cash flow in the past year.
Each year in the past 5 years MANH has been profitable.
In the past 5 years MANH always reported a positive cash flow from operatings.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

Looking at the Return On Assets, with a value of 29.70%, MANH belongs to the top of the industry, outperforming 97.51% of the companies in the same industry.
With an excellent Return On Equity value of 79.34%, MANH belongs to the best of the industry, outperforming 97.86% of the companies in the same industry.
MANH has a better Return On Invested Capital (65.54%) than 99.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MANH is significantly above the industry average of 11.98%.
The 3 year average ROIC (55.23%) for MANH is below the current ROIC(65.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 29.7%
ROE 79.34%
ROIC 65.54%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

MANH has a Profit Margin of 20.91%. This is amongst the best in the industry. MANH outperforms 85.77% of its industry peers.
MANH's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 25.43%, MANH belongs to the top of the industry, outperforming 89.68% of the companies in the same industry.
In the last couple of years the Operating Margin of MANH has grown nicely.
MANH has a Gross Margin of 56.28%. This is in the lower half of the industry: MANH underperforms 65.12% of its industry peers.
MANH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.43%
PM (TTM) 20.91%
GM 56.28%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MANH is creating value.
The number of shares outstanding for MANH has been reduced compared to 1 year ago.
Compared to 5 years ago, MANH has less shares outstanding
There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MANH has an Altman-Z score of 18.80. This indicates that MANH is financially healthy and has little risk of bankruptcy at the moment.
MANH's Altman-Z score of 18.80 is amongst the best of the industry. MANH outperforms 93.24% of its industry peers.
There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 18.8
ROIC/WACC5.79
WACC11.32%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.19 indicates that MANH should not have too much problems paying its short term obligations.
MANH's Current ratio of 1.19 is on the low side compared to the rest of the industry. MANH is outperformed by 62.99% of its industry peers.
MANH has a Quick Ratio of 1.19. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.19, MANH is not doing good in the industry: 62.63% of the companies in the same industry are doing better.
MANH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.02% over the past year.
MANH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.14% yearly.
The Revenue has been growing slightly by 6.14% in the past year.
Measured over the past years, MANH shows a quite strong growth in Revenue. The Revenue has been growing by 11.02% on average per year.
EPS 1Y (TTM)17.02%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%11.02%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%2.68%

3.2 Future

MANH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.76% yearly.
Based on estimates for the next years, MANH will show a quite strong growth in Revenue. The Revenue will grow by 8.08% on average per year.
EPS Next Y3.7%
EPS Next 2Y6.28%
EPS Next 3Y10.13%
EPS Next 5Y17.76%
Revenue Next Year3.4%
Revenue Next 2Y5.02%
Revenue Next 3Y6.4%
Revenue Next 5Y8.08%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 41.44, MANH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MANH indicates a somewhat cheap valuation: MANH is cheaper than 60.85% of the companies listed in the same industry.
MANH is valuated rather expensively when we compare the Price/Earnings ratio to 27.76, which is the current average of the S&P500 Index.
MANH is valuated quite expensively with a Price/Forward Earnings ratio of 38.94.
MANH's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.21, MANH is valued quite expensively.
Industry RankSector Rank
PE 41.44
Fwd PE 38.94
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MANH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MANH is cheaper than 67.26% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MANH is valued a bit cheaper than the industry average as 65.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 40.94
EV/EBITDA 42.84
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MANH does not grow enough to justify the current Price/Earnings ratio.
MANH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)11.21
PEG (5Y)1.87
EPS Next 2Y6.28%
EPS Next 3Y10.13%

0

5. Dividend

5.1 Amount

MANH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (10/8/2025, 3:14:55 PM)

208.05

+9.1 (+4.57%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners103.5%
Inst Owner Change0%
Ins Owners1.24%
Ins Owner Change-2.58%
Market Cap12.58B
Analysts78.82
Price Target233.25 (12.11%)
Short Float %3%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.8%
Min EPS beat(2)13.66%
Max EPS beat(2)13.93%
EPS beat(4)4
Avg EPS beat(4)15.06%
Min EPS beat(4)8.28%
Max EPS beat(4)24.36%
EPS beat(8)8
Avg EPS beat(8)19.75%
EPS beat(12)12
Avg EPS beat(12)22.74%
EPS beat(16)16
Avg EPS beat(16)23.8%
Revenue beat(2)2
Avg Revenue beat(2)0.85%
Min Revenue beat(2)0.44%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.26%
Revenue beat(8)6
Avg Revenue beat(8)1.49%
Revenue beat(12)10
Avg Revenue beat(12)2.96%
Revenue beat(16)14
Avg Revenue beat(16)3%
PT rev (1m)0%
PT rev (3m)13.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.06%
EPS NY rev (1m)0%
EPS NY rev (3m)4.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.2%
Valuation
Industry RankSector Rank
PE 41.44
Fwd PE 38.94
P/S 11.89
P/FCF 40.94
P/OCF 39.77
P/B 45.13
P/tB 58.11
EV/EBITDA 42.84
EPS(TTM)5.02
EY2.41%
EPS(NY)5.34
Fwd EY2.57%
FCF(TTM)5.08
FCFY2.44%
OCF(TTM)5.23
OCFY2.51%
SpS17.49
BVpS4.61
TBVpS3.58
PEG (NY)11.21
PEG (5Y)1.87
Profitability
Industry RankSector Rank
ROA 29.7%
ROE 79.34%
ROCE 79.69%
ROIC 65.54%
ROICexc 206.87%
ROICexgc 495.06%
OM 25.43%
PM (TTM) 20.91%
GM 56.28%
FCFM 29.05%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
ROICexc(3y)379.42%
ROICexc(5y)338.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)67.16%
ROCE(5y)58.04%
ROICexcg growth 3YN/A
ROICexcg growth 5Y6.89%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y14.68%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
F-Score7
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 139.79%
Cap/Sales 0.85%
Interest Coverage 250
Cash Conversion 114.85%
Profit Quality 138.95%
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 18.8
F-Score7
WACC11.32%
ROIC/WACC5.79
Cap/Depr(3y)106.14%
Cap/Depr(5y)79.88%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.65%
Profit Quality(3y)134%
Profit Quality(5y)144.89%
High Growth Momentum
Growth
EPS 1Y (TTM)17.02%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%11.02%
EPS Next Y3.7%
EPS Next 2Y6.28%
EPS Next 3Y10.13%
EPS Next 5Y17.76%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%2.68%
Revenue Next Year3.4%
Revenue Next 2Y5.02%
Revenue Next 3Y6.4%
Revenue Next 5Y8.08%
EBIT growth 1Y12.98%
EBIT growth 3Y24.89%
EBIT growth 5Y17.68%
EBIT Next Year8.29%
EBIT Next 3Y8.86%
EBIT Next 5Y11.24%
FCF growth 1Y63.2%
FCF growth 3Y16.48%
FCF growth 5Y16.8%
OCF growth 1Y62.71%
OCF growth 3Y16.79%
OCF growth 5Y14.96%